Teva discontinued propofol in 2010, but will reenter the market because of the drug shortage.
Maker Fresenius has increased its drug production, and the FDA will continue to import Propoven, a similar drug, from overseas.
ASA is working closely with the FDA to mitigate and prevent further drug shortages.
More Articles on Anesthesia:
MEDNAX Completes South Oakland Anesthesia Associates Acquisition
FDA Approves ARROW UltraQuik Needles
Somnia Anesthesia Releases New Case Studies on Anesthesia Leadership
